Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus

References

• Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000; 23:95 - 108; http://dx.doi.org/10.2337/diacare.23.1.95; PMID: 10857977
   PubMed Web of Science ®Google Scholar
• Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181:831 - 7; http://dx.doi.org/10.1086/315320; PMID: 10720501
   PubMed Web of Science ®Google Scholar
• Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41:281 - 8; http://dx.doi.org/10.1086/431587; PMID: 16007521
   PubMed Web of Science ®Google Scholar
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46:RR-9 1 - 25; PMID: 9148134
   PubMedGoogle Scholar
• Smith SA, Poland GA, American Diabetes Association. Influenza and pneumococcal immunization in diabetes. Diabetes Care 2004; 27:Suppl 1 S111 - 3; http://dx.doi.org/10.2337/diacare.27.2007.S111; PMID: 14693944
   PubMedGoogle Scholar
• New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009; 84:249 - 57; PMID: 19537358
   PubMedGoogle Scholar
• Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405 - 13; http://dx.doi.org/10.1056/NEJMoa0907413; PMID: 19745216
   PubMed Web of Science ®Google Scholar
• Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197 - 201; http://dx.doi.org/10.1126/science.1176225; PMID: 19465683
   PubMed Web of Science ®Google Scholar
• Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, Li RC, Xia SL, Zhao YL, Li FJ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010; 375:56 - 66; http://dx.doi.org/10.1016/S0140-6736(09)62003-1; PMID: 20018364
   PubMed Web of Science ®Google Scholar
• Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, Zhang XF, Pan HX, Meng FY, Hu YM, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414 - 23; http://dx.doi.org/10.1056/NEJMoa0908535; PMID: 19846844
   PubMed Web of Science ®Google Scholar
• Ohfuji S, Fukushima W, Tamori A, Maeda K, Maeda A, Hirota Y. Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C. Influenza Other Respir Viruses 2013; 7:456 - 65; http://dx.doi.org/10.1111/j.1750-2659.2012.00424.x; PMID: 22897938
   PubMed Web of Science ®Google Scholar
• Kao TM, Hsieh SM, Kung HC, Lee YC, Huang KC, Huang LM, Chang FY, Wang NC, Liu YC, Lee WS, et al. Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly. Vaccine 2010; 28:6159 - 63; http://dx.doi.org/10.1016/j.vaccine.2010.07.026; PMID: 20659517
   PubMed Web of Science ®Google Scholar
• Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine 2006; 24:5371 - 80; http://dx.doi.org/10.1016/j.vaccine.2006.04.032; PMID: 16713661
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159 - 69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105; PMID: 16213065
   PubMed Web of Science ®Google Scholar
• Fülöp T Jr., Wagner JR, Khalil A, Weber J, Trottier L, Payette H. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol A Biol Sci Med Sci 1999; 54:M59 - 64; http://dx.doi.org/10.1093/gerona/54.2.M59; PMID: 10051856
   PubMedGoogle Scholar
• Bellei NC, Carraro E, Castelo A, Granato CF. Risk factors for poor immune response to influenza vaccination in elderly people. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 2006; 10:269 73
   PubMedGoogle Scholar
• Hara M, Tanaka K, Hirota Y. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine 2005; 23:1457 - 63; http://dx.doi.org/10.1016/j.vaccine.2004.09.022; PMID: 15670881
   PubMed Web of Science ®Google Scholar
• Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172:3437 - 46; PMID: 15004143
   PubMed Web of Science ®Google Scholar
• Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004; 173:673 - 81; PMID: 15210831
   PubMed Web of Science ®Google Scholar
• Saurwein-Teissl M, Lung TL, Marx F, Gschösser C, Asch E, Blasko I, Parson W, Böck G, Schönitzer D, Trannoy E, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168:5893 - 9; PMID: 12023394
   PubMed Web of Science ®Google Scholar
• Sagawa M, Kojimahara N, Otsuka N, Kimura M, Yamaguchi N. Immune response to influenza vaccine in the elderly: association with nutritional and physical status. Geriatr Gerontol Int 2011; 11:63 - 8; http://dx.doi.org/10.1111/j.1447-0594.2010.00641.x; PMID: 20738411
   PubMed Web of Science ®Google Scholar
• Delespesse G, Duchateau J, Bastenie PA, Lauvaux JP, Collet H, Govaerts A. Cell-mediated immunity in diabetes mellitus. Clin Exp Immunol 1974; 18:461 - 7; PMID: 4283119
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Gale EA, Visalli N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreani D. The immune response to influenza vaccination in diabetic patients. Diabetologia 1986; 29:850 - 4; http://dx.doi.org/10.1007/BF00870139; PMID: 3569690
   PubMed Web of Science ®Google Scholar
• Nam JS, Kim AR, Yoon JC, Byun Y, Kim SA, Kim KR, Cho S, Seong BL, Ahn CW, Lee JM. The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in Korea. Diabetic medicine: a journal of the British Diabetic Association 2011; 28:815 7
   PubMed Web of Science ®Google Scholar
• Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics 2006; 118:e579 - 85; http://dx.doi.org/10.1542/peds.2006-0201; PMID: 16950949
   PubMedGoogle Scholar
• Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032 - 9; http://dx.doi.org/10.1086/507309; PMID: 16991077
   PubMed Web of Science ®Google Scholar
• Parkman PD, Hopps HE, Rastogi SC, Meyer HM Jr.. Summary of clinical trials of influenza virus vaccines in adults. J Infect Dis 1977; 136:Suppl S722 - 30; http://dx.doi.org/10.1093/infdis/136.Supplement_3.S722; PMID: 606797
   PubMed Web of Science ®Google Scholar
• Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006; 12:29 - 33; http://dx.doi.org/10.3201/eid1201.051007; PMID: 16494713
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006; 354:1343 - 51; http://dx.doi.org/10.1056/NEJMoa055778; PMID: 16571878
   PubMed Web of Science ®Google Scholar
• Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, et al. Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis 2012; 206:811 - 20; http://dx.doi.org/10.1093/infdis/jis427; PMID: 22782949
   PubMed Web of Science ®Google Scholar
• Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361:2424 - 35; http://dx.doi.org/10.1056/NEJMoa0907650; PMID: 19745215
   PubMed Web of Science ®Google Scholar
• Hirst GK. The Quantitative Determination of Influenza Virus and Antibodies by Means of Red Cell Agglutination. J Exp Med 1942; 75:49 - 64; http://dx.doi.org/10.1084/jem.75.1.49; PMID: 19871167
   PubMedGoogle Scholar